CAS 1949837-12-0

ARV-771

CAS : 1949837-12-0

ARV-771

Degré de pureté : ≥98%

Masse moléculaire : 986.64g/mol

Ref: 54-BUP04752

(2S,4R)-1-((2S)-2-(Tert-Butyl)-15-((6S)-4-(4-Chlorophenyl)-2,3,9-Trimethyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepin-6-Yl)-4,14-Dioxo-6,10-Dioxa-3,13-Diazapentadecan-1-Oyl)-4-Hydroxy-N-((S)-

CAS : 1949837-12-0

(2S,4R)-1-((2S)-2-(Tert-Butyl)-15-((6S)-4-(4-Chlorophenyl)-2,3,9-Trimethyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepin-6-Yl)-4,14-Dioxo-6,10-Dioxa-3,13-Diazapentadecan-1-Oyl)-4-Hydroxy-N-((S)-

Degré de pureté : 97%

Masse moléculaire : 986.64g/mol

Ref: 54-OR1023864

ARV-771

CAS : 1949837-12-0

ARV-771 is an effective BET degrader based on PROTAC technology.Cost-effective and quality-assured.

Formule : C₄₉H₆₀ClN₉O₇S₂

Degré de pureté : 99.69%

Couleur et forme : Solid

Masse moléculaire : 986.64

Ref: TM-T5435

ARV-771

CAS : 1949837-12-0

Degré de pureté : 98%

Masse moléculaire : 986.65

Ref: 10-F987729

ARV-771

Produit contrôlé

CAS : 1949837-12-0

ARV-771 is a peptide that activates the G protein-coupled receptor. ARV-771 is a potent agonist of both alpha and beta adrenergic receptors and has been shown to have no effect on alpha-adrenergic receptors. The peptide was first isolated from porcine brain, but has since been synthesized in the laboratory. ARV-771 has a high affinity for the beta 1 adrenergic receptor and can be used as an antagonist by blocking the binding of epinephrine or norepinephrine at this receptor. It may also be used as an inhibitor of ligand binding to cell surface receptors such as ion channels and antibodies.

Formule : C₄₉H₆₀ClN₉O₇S₂

Degré de pureté : Min. 95%

Masse moléculaire : 986.64 g/mol

Ref: 3D-ZCD83712